Alyeska Investment Group’s Ocugen OCGN Stock Holding History

Alyeska Investment Group’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,500,000	Closed	-$1.36M	–	589
2023 Q2	$1.36M	Buy	+2,500,000	New	+$1.6M	0.01%	435

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Alyeska Investment Group's OCGN Position: Q3 2023 in Review

Alyeska Investment Group sold out of Ocugen (OCGN) in Q3 2023, closing a stake of 2,500,000 shares — an estimated $1.36M sold.

Alyeska Investment Group first reported a position in OCGN in Q2 2023 and held it in 1 quarter. The position peaked at $1.36M in Q2 2023. 78 funds tracked by Wall St. Rank hold OCGN as of Q3 2023.

Alyeska Investment Group reported no remaining Ocugen position as of Q3 2023 after selling out during the quarter.
Alyeska Investment Group sold 2,500,000 Ocugen shares in Q3 2023, an estimated $1.36M.
Alyeska Investment Group first reported a position in Ocugen in Q2 2023 and held it in 1 quarter.
Alyeska Investment Group's Ocugen position peaked at $1.36M in Q2 2023.
78 funds tracked by Wall St. Rank held Ocugen as of Q3 2023.

Based on Alyeska Investment Group's 13F filing for Q3 2023, filed 14 Nov 2023.